We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Computer Program Predicts Drug Resistance by Evaluating Whole Genome Sequencing Data

By LabMedica International staff writers
Posted on 03 Jan 2016
Print article
Image: A screenshot from the Mykrobe Predictor software package shows results for an analysis of a methicillin-resistant Staphylococcus aureus (MRSA) bacterium (Photo courtesy of Mykrobe [University of Oxford]).
Image: A screenshot from the Mykrobe Predictor software package shows results for an analysis of a methicillin-resistant Staphylococcus aureus (MRSA) bacterium (Photo courtesy of Mykrobe [University of Oxford]).
A software package is being evaluated in the United Kingdom that can identify a bacterium from the DNA sequence of its genome and predict which antibiotics will kill it.

The Mykrobe Predictor software for laptop and tablet computer use was developed by investigators at the University of Oxford (United Kingdom). It supports Illumina Inc. (San Diego, CA, USA) instrument sequencing data as standard input. Antibiotics supported include: Beta-lactams (methicillin, penicillin), quinolones (ciprofloxacin), macrolides/lincosamides (erythromycin, clindamycin), tetracycline, aminoglycosides (gentamicin), glycopeptides (vancomycin), rifampicin, mupirocin, fusidic acid, and trimethoprim.

The program takes raw sequence data as input and generates a clinician-friendly report within three minutes on a laptop or tablet computer.

Mykrobe Predictor is currently being evaluated in three medical centers in the United Kingdom. A preliminary study comprising more than 4,500 retrospective patient samples was published in the December 21, 2015, online edition of the journal Nature Communications. Results highlighted the ability of the Mykrobe Predictor program to accurately detect antibiotic resistance in two life-threatening bacterial infections: Staphylococcus aureus (including MRSA) and Mycobacterium tuberculosis (TB).

For S. aureus, the error rates of the method were comparable to gold-standard phenotypic methods, with sensitivity/specificity of 99.1%/99.6% across 12 antibiotics. For M. tuberculosis, the method predicted resistance with sensitivity/specificity of 82.6%/98.5%. Sensitivity was lower for M. tuberculosis, probably because of limited understanding of the underlying genetic mechanisms.

The program also identified infections caused by a mixture of drug-resistant and drug-susceptible bacteria. This ability to distinguish between bacterial sub-populations gave the Mykrobe Predictor program an advantage over conventional testing in detecting resistance to second-line TB drugs.

Senior author Dr. Zamin Iqbal, a researcher in human genetics at the University of Oxford, said, "One of the barriers to making whole genome sequencing a routine part of NHS care is the need for powerful computers and expertise to interpret the masses of complex data. Our software manages data quickly and presents the results to doctors and nurses in ways that are easy to understand, so they can instinctively use them to make better treatment decisions."

Related Links:

University of Oxford
Mykrobe Predictor
Illumina Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.